(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 19.53 | 30.85 | -36.69 | 61.89 | 65.98 | -6.20 | 61.89 | 65.98 | -6.20 |
| Other Income | 0.03 | 0.15 | -80.00 | 0.07 | 0.15 | -53.33 | 0.07 | 0.15 | -53.33 |
| PBIDT | 5.53 | 3.93 | 40.71 | 11.95 | 9.59 | 24.61 | 11.95 | 9.59 | 24.61 |
| Interest | 1.40 | 0.39 | 258.97 | 2.30 | 1.49 | 54.36 | 2.30 | 1.49 | 54.36 |
| PBDT | 4.13 | 3.54 | 16.67 | 9.65 | 8.10 | 19.14 | 9.65 | 8.10 | 19.14 |
| Depreciation | 1.97 | 0.65 | 203.08 | 3.95 | 2.64 | 49.62 | 3.95 | 2.64 | 49.62 |
| PBT | 2.16 | 2.89 | -25.26 | 5.70 | 5.46 | 4.40 | 5.70 | 5.46 | 4.40 |
| TAX | 0.89 | 1.27 | -29.92 | 0.89 | 1.27 | -29.92 | 0.89 | 1.27 | -29.92 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 1.27 | 1.62 | -21.60 | 4.81 | 4.19 | 14.80 | 4.81 | 4.19 | 14.80 |
| Equity | 44.38 | 44.38 | 0.00 | 44.38 | 44.38 | 0.00 | 44.38 | 44.38 | 0.00 |
| PBIDTM(%) | 28.32 | 12.74 | 122.27 | 19.31 | 14.53 | 32.84 | 19.31 | 14.53 | 32.84 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: